Target Name: C8orf89
NCBI ID: G100130301
Review Report on C8orf89 Target / Biomarker Content of Review Report on C8orf89 Target / Biomarker
C8orf89
Other Name(s): Putative uncharacterized protein C8orf89 | C8orf89 variant 1 | CH089_HUMAN | Chromosome 8 open reading frame 89, transcript variant 1 | uncharacterized protein LOC100130301 | Putative uncharacterized protein C8orf89 (isoform a) | uncharacterized LOC100130301 | chromosome 8 open reading frame 89

C8ORF89: A Potential Drug Target and Biomarker

C8ORF89 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is located in chromosome 8 and has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. The discovery of C8ORF89 as a potential drug target has significant implications for the development of new treatments for a variety of diseases.

C8ORF89 as a Drug Target

C8ORF89 has been shown to be involved in several cellular processes that are crucial for the growth, survival, and progression of cancer cells. One of the most significant functions of C8ORF89 is its role in cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. C8ORF89 is known to be involved in the formation of tight junctions, which are essential for maintaining tissue structure and function.

In addition to its role in cell adhesion, C8ORF89 has also been shown to be involved in cell migration. Migration is the process by which cells move from one location to another in order to perform their desired functions. C8ORF89 has been shown to play a role in the regulation of cell migration, which is essential for the development and progression of cancer.

C8ORF89 has also been shown to be involved in the regulation of cell invasion. Invasion is the process by which cells break through the lining of the body's various tissues and enter new areas. C8ORF89 has been shown to play a role in the regulation of cell invasion, which is essential for the development and progression of cancer.

C8ORF89 as a Biomarker

The identification of C8ORF89 as a potential drug target has significant implications for the development of new treatments for a variety of diseases. C8ORF89 has also been shown to be a potential biomarker for several diseases, including cancer.

C8ORF89 has been shown to be involved in the regulation of various cellular processes that are crucial for the growth, survival, and progression of cancer cells. As a result, C8ORF89 has the potential to be used as a biomarker for the diagnosis and treatment of cancer.

C8ORF89 has also been shown to be involved in the regulation of inflammation. Inflammation is a natural response of the immune system to injury or infection. However, chronic inflammation can lead to a variety of diseases, including cancer. C8ORF89 has been shown to play a role in the regulation of inflammation, which has implications for the development of new treatments for inflammatory diseases.

Conclusion

In conclusion, C8ORF89 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its role in cell adhesion, migration, and invasion, as well as its potential as a biomarker for the diagnosis and treatment of cancer, makes C8ORF89 an important target for further research. Further studies are needed to fully understand the functions of C8ORF89 and its potential as a drug and biomarker.

Protein Name: Chromosome 8 Open Reading Frame 89

The "C8orf89 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C8orf89 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

C9 | C9orf131 | C9orf152 | C9orf153 | C9orf163 | C9orf24 | C9orf40 | C9orf43 | C9orf47 | C9orf50 | C9orf57 | C9orf64 | C9orf72 | C9orf78 | C9orf78P2 | C9orf85 | CA1 | CA10 | CA11 | CA12 | CA13 | CA14 | CA15P1 | CA2 | CA3 | CA3-AS1 | CA4 | CA5A | CA5B | CA5BP1 | CA6 | CA7 | CA8 | CA9 | CAAP1 | CAB39 | CAB39L | CABCOCO1 | CABIN1 | CABLES1 | CABLES2 | CABP1 | CABP2 | CABP4 | CABP5 | CABP7 | CABS1 | CABYR | CACFD1 | CACHD1 | CACNA1A | CACNA1B | CACNA1C | CACNA1C-AS4 | CACNA1C-IT2 | CACNA1C-IT3 | CACNA1D | CACNA1E | CACNA1F | CACNA1G | CACNA1G-AS1 | CACNA1H | CACNA1I | CACNA1S | CACNA2D1 | CACNA2D1-AS1 | CACNA2D2 | CACNA2D3 | CACNA2D4 | CACNB1 | CACNB2 | CACNB3 | CACNB4 | CACNG1 | CACNG2 | CACNG2-DT | CACNG3 | CACNG4 | CACNG5 | CACNG6 | CACNG7 | CACNG8 | CACTIN | CACTIN-AS1 | CACUL1 | CACYBP | CAD | CADM1 | CADM2 | CADM3 | CADM3-AS1 | CADM4 | CADPS | CADPS2 | CAGE1 | CAHM | CALB1 | CALB2 | CALCA | CALCB